Document Detail

Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis.
MedLine Citation:
PMID:  23149707     Owner:  NLM     Status:  Publisher    
Calcipotriol, a vitamin D analogue, and betamethasone dipropionate, a high potency corticosteroid, are complementary agents for the topical treatment of psoriasis vulgaris. Robust evidence on the efficacy and safety of their fixed combination has been provided by randomized, double-blind, controlled clinical trials involving more than 7000 patients with the ointment formulation in psoriasis of the body and more than 4000 patients with the gel formulation in scalp psoriasis. These trials have shown that the fixed combination ointment is more effective and better tolerated, not only than placebo, but also than calcipotriol and tacalcitol monotherapies. In addition, it has proved, in most instances, to be more effective than betamethasone and at least as well tolerated. The same applies to the gel for scalp and body psoriasis. Safety studies have excluded that repeated courses of treatment with the fixed combination for up to one year produce systemic effects. Studies have also shown that the fixed combination treatment improves quality of life to a significantly greater extent than calcipotriol, with the once daily regimen most appreciated by patients, in both active disease and recurrency. Because of the extensive evidence, American and European guidelines recommend the calcipotriol/betamethasone dipropionate fixed combination as first line topical treatment for mild to moderate plaque psoriasis of the body and scalp.
G Girolomoni; G A Vena; F Ayala; S P Cannavò; O De Pità; S Chimenti; A Peserico
Related Documents :
23016867 - Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chroni...
15468367 - Equivalence study of a topical diclofenac solution (pennsaid) compared with oral diclof...
12166347 - Gastrointestinal tolerability of ibuprofen compared with paracetamol and aspirin at ove...
23080237 - A randomized controlled trial to evaluate an antimicrobial dressing with silver alginat...
1477017 - A randomised placebo controlled trial of labetalol in the treatment of mild to moderate...
22122217 - Web-based cognitive-behavioral therapy for perfectionism: a randomized controlled trial.
Publication Detail:
Journal Detail:
Title:  Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia     Volume:  147     ISSN:  0392-0488     ISO Abbreviation:  G Ital Dermatol Venereol     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102852     Medline TA:  G Ital Dermatol Venereol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  609-624     Citation Subset:  -    
Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy -
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary.
Next Document:  Efficacy of Iralfaris shampoo in the treatment of scalp psoriasis: a videodermoscopy evaluation pros...